What is Teckro, Inc.?
Headquartered in Limerick, Ireland, Teckro, Inc. provides a sophisticated digital engagement platform designed to connect all stakeholders within the clinical trial ecosystem. By digitizing the traditionally fragmented communication and data-sharing processes, Teckro enables pharmaceutical companies and research organizations to enhance trial transparency, compliance, and efficiency. The platform serves as a centralized hub for trial protocols, real-time updates, and stakeholder interaction, effectively reducing the administrative burden that often plagues large-scale medical research. As the industry shifts toward decentralized and hybrid trial models, Teckro's technology is positioned as a critical enabler for global drug development programs across diverse therapeutic areas.
How much funding has Teckro, Inc. raised?
Teckro, Inc. has raised a total of $41M across 3 funding rounds:
Series A
$6M
Series B
$10M
Series C
$25M
Series A (2016): $6M with participation from Founders Fund and Enterprise Ireland
Series B (2017): $10M led by Section 32, Sands Capital Ventures, and Founders Fund
Series C (2019): $25M supported by Northpond Ventures, Sands Capital Ventures, Founders Fund, Borealis Ventures, and Section 32
Key Investors in Teckro, Inc.
Founders Fund
Founders Fund invests in the world's most important and valuable companies across all geographies, sectors and stages, pursuing a founder-friendly investment strategy.
Sands Capital Ventures
Established in 1992, Sands Capital Management is a firm that manages equity mutual funds and invests in public equity markets with a focus on long-term growth.
Section 32
A venture capital firm founded by Bill Maris that focuses on investing in cutting-edge technology and supporting visionary entrepreneurs at the forefront of innovation.
What's next for Teckro, Inc.?
With the support of its high-profile investor base, Teckro is well-positioned to deepen its market penetration and expand its suite of digital tools. The current funding context suggests a strategic focus on scaling operations to meet the needs of large-scale enterprise clients, potentially through enhanced data analytics capabilities and broader integration with existing clinical trial management systems. As the company matures, the focus will likely shift toward maintaining its competitive edge in the rapidly evolving health-tech landscape, ensuring that its platform remains the gold standard for digital stakeholder engagement in clinical research. Future growth will likely be driven by continued adoption among top-tier pharmaceutical companies seeking to optimize their research pipelines through digital transformation.
See full Teckro, Inc. company page
